White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back…
Vertex Pharma’s Flagship Cystic Fibrosis Drug Scores FDA Approval For Infants
The FDA has approved Vertex Pharmaceuticals Incorporated’s (NASDAQ:VRTX) Orkambi (lumacaftor/ivacaftor) for expanded use to include children with cystic fibrosis (CF) ages…
Veterans File Lawsuit To Block 3M Healthcare Spinoff: Report
Two U.S. military veterans have reportedly sued 3M Co (NYSE:MMM) to block the planned spinoff of its healthcare business, calling it…
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
Raymond James initiated coverage on AnaptysBio Inc (NASDAQ:ANAB) with an Outperform rating and a $35 price target. The analyst has a positive…
Johnson & Johnson To Settle New Hampshire Opioid Lawsuit With Payment Of $40.5M: Report
Reuters reported that Johnson & Johnson (NYSE:JNJ) would pay $40.5 million to settle 2018 New Hampshire’s claims about the U.S. opioid epidemic,…
PolyPid’s Lead Program Flunks Abdominal Surgery Study, Shares Tank
PolyPid Ltd (NASDAQ: PYPD) shares lost almost 80% after announcing topline results from the SHIELD I Phase 3 study of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal surgery.
Philips’ Subsidiary To Pay Over $24M For Alleged False Claims For Respiratory-Related Equipment
Koninklijke Philips NV (NYSE:PHG) has agreed to pay over $24 million to resolve alleged false claims over respiratory-related medical…
Motorola Solutions’ CEO Sees ‘Strongest Demand Environment’
In an interview, Motorola Solutions Inc (NYSE:MSI) CEO Greg Brown told CNBC that demand for the company’s public safety and enterprise security…
Credit Suisse Considers Axing 5,000 Jobs In Cost Reduction Drive: Report
Credit Suisse Group AG (NYSE:CS) is planning to cut around 5,000 jobs as part of a cost reduction drive, Reuters…